Anna Mosbech is a highly experienced scientist currently serving as a Senior Principal Scientist at ALK, where responsibilities include analytical development and validation of various analytical methods. Previously, Anna held several roles at the Biotech Research & Innovation Centre (BRIC) at the University of Copenhagen, including Postdoc in Theilgaard Group, focusing on the hematopoietic system and acute myeloid leukaemia. Anna's research background includes a Ph.D. from Københavns Universitet, studying ubiquitin signaling pathways in relation to DNA damage, and experience at Novo Nordisk as a Master thesis student, where integrin-mediated processes in human T lymphocytes were investigated. Early experience includes positions as a Student Assistant at Pfizer Danmark and a Bachelor Student at Rigshospitalet, addressing drug safety and colorectal cancer diagnostics, respectively. Anna's education includes an M.Sc. in Biotechnology from DTU and a background in mathematics and chemistry from Herlev Gymnasium.
This person is not in any teams
This person is not in any offices